Sofía Soler

Ms. Sofía Soler

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
JHJanine Holze
Janine Holze
FLFelicitas Lauber
Felicitas Lauber
SSSofía Soler
Sofía Soler
EKEvi Kostenis
Evi Kostenis
Günther WeindlGünther Weindl
Günther Weindl
The discovery of Toll-like receptors (TLRs) represented a significant breakthrough that paved the way for the study of host-pathogen interactions in innate immunity. However, there are still major gaps in understanding TLR function, especially regarding the early dynamics of downstream TLR pathways. Here, we present a label-free optical biosensor-based assay as a method for detecting TLR activation in a native and label-free environment and defining the dynamics of TLR pathway activation. This technology is sufficiently sensitive to detect TLR signaling and readily discriminates between different TLR signaling pathways. We define pharmacological modulators of cell surface and endosomal TLRs and downstream signaling molecules and uncover TLR signaling signatures, including potential biased receptor signaling. These findings highlight that optical biosensor assays complement traditional assays that use a single endpoint and have the potential to facilitate the future design of selective drugs targeting TLRs and their downstream effector cascades.

Verified
Journal Article
Open access
PDF file
AMA A Mohamed
A A Mohamed
SSSofía Soler
Sofía Soler
JWJulia Wegner
Julia Wegner
EBEva Bartok
Eva Bartok
SSSanda Stankovic
Sanda Stankovic
MSMartin Schlee
Martin Schlee
Immune surveillance by natural killer (NK) cells and their recruitment to sites of inflammation renders them susceptible to viral infection, potentially modulating their effector function. Here, we analyzed innate RNA receptor signaling in NK cells downstream of direct Influenza A virus (IAV) infection and its impact on NK cell effector function. Infection of NK cells with IAV resulted in the activation of TBK1, NF-ϰB and subsequent type-I IFN secretion. CRISPR-generated knockouts in primary human NK cells revealed that this effect depended on the antiviral cytosolic RNA receptor RIG-I. Transfection of NK cells with synthetic 3p-dsRNA, a strong RIG-I agonist that mimics viral RNA, resulted in a similar phenotype and rendered NK cells resistant to subsequent IAV infection. Strikingly, both IAV infection and 3p-dsRNA transfection enhanced degranulation and cytokine production by NK cells when exposed to target cells. Thus, RIG-I activation in NK cells both supports their cell intrinsic viral defense and enhances their cytotoxic effector function against target cells.

25 August 2023 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
KAKatarzyna Andryka-Cegielski
Katarzyna Andryka-Cegielski
SSSofía Soler
Sofía Soler
EBEva Bartok
Eva Bartok
In their recently published study in Nature, Jenson et al. 1 provide compelling, unexpected evidence that bacterial cGAMP synthase (cGAS) and other cGAS/DncV-like Nucleotidyltransferases (CD-NTase) undergo ubiquitin-like conjugation (ULC) in type-II cyclic-oligonucleotide-based anti-phage signaling systems (CBASS). cGAS conjugation promotes cyclic-nucleotide (CN) formation and thus antiphage defense. Furthermore, the authors also reveal a new class of phage-encoded CBASS inhibitor, T4 Vs.4, a CN-sponge which limits CBASS effector function and promotes phage replication, revealing another weapon in the "arms race" between phages and their bacterial hosts. CN-based signaling is a common element in the antiviral immunity of bacteria, archaea, and metazoans. Bacterial CBASS is essential to antiphage defense and is closely evolutionarily linked to the metazoan antiviral pathway cGAS /STimulator of INterferon Genes (STING). In vertebrates, cGAS has evolved into a receptor for double-stranded DNA, which, upon activation, catalyzes the formation 2'-3'-cGAMP, the ligand for STING, leading to the production of the key vertebrate antiviral cytokine, type-I interferon. This pathway is essential to our own immune defense against numerous bacterial and viral pathogens. As a minimal functional unit, CBASS contains two similar genes: (i) CD-NTase (also termed cGAS in E. coli), which, after an unknown activation mechanism, catalyzes the synthesis of CN second messengers and (ii) Cap, which, like metazoan STING, senses CN and carries out signaling and effector functions, including cell death programs. However, the type-II CBASS operon also encodes two ancillary genes, Cap2 and Cap3 2 (Fig. 1), that surprisingly contain domains resembling eukaryotic ubiquitin-activating (E1, Cap2),-conjugating (E2, Cap2) and-deconjugating (JAB/JAMM, Cap3) enzymes. Little is known about protein conjugation in bacteria, and, although it had previously been shown that the enzymatic activities of Cap2 and Cap3 promote antiphage defense, 3 the potential targets of these de/conjugating enzymes and their downstream molecular mechanisms remained completely unclear. To address these questions, Jenson and colleagues utilized a straightforward but effective approach: E.coli MG1655, which lacks CBASS, was used for the expression of diverse type-II CBASS systems 3 and modifications thereof throughout the manuscript (Fig. 1). In initial experiments, FLAG-Cap2 was incorporated into E. coli TW11681 CBASS to identify interactors via immunoprecipitation, and putative loss-of-function (LOF) Cap2 and Cap3 mutants 3

26 June 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
AMA A Mohamed
A A Mohamed
SSSofía Soler
Sofía Soler
JWJulia Wegner
Julia Wegner
EBEva Bartok
Eva Bartok
SSSanda Stankovic
Sanda Stankovic
MSMartin Schlee
Martin Schlee
Immune surveillance by natural killer (NK) cells and their recruitment to sites of inflammation renders them susceptible to viral infection, potentially modulating their effector function. Here, we analyzed innate RNA receptor signaling in NK cells downstream of direct Influenza A virus (IAV) infection and its impact on NK cell effector function. Infection of NK cells with IAV resulted in the activation of TBK1, NF-κB and subsequent type-I IFN secretion. CRISPR- generated knockouts in primary human NK cells revealed that this effect depended on the antiviral cytosolic RNA receptor RIG-I. Transfection of NK cells with synthetic 3p-dsRNA, a strong RIG-I agonist that mimics viral RNA, resulted in a similar phenotype and rendered NK cells resistant to subsequent IAV infection. Strikingly, both IAV infection and 3p-dsRNA transfection enhanced degranulation and cytokine production by NK cells when exposed to target cells. Thus, RIG-I activation in NK cells both supports their cell intrinsic viral defense and enhances their cytotoxic effector function against target cells.